Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Nemaura Med Inc (NMRD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 87,226
  • Shares Outstanding, K 22,894
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,160 K
  • 60-Month Beta -0.45
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 39.42
Trade NMRD with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.13
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/09/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    Medical Instruments

    Indices Russell 2000

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.40 +8.53%
on 10/01/20
4.25 -13.18%
on 10/16/20
+0.03 (+0.82%)
since 09/25/20
3-Month
3.12 +18.37%
on 09/25/20
10.66 -65.38%
on 07/27/20
-5.78 (-61.03%)
since 07/24/20
52-Week
2.50 +47.60%
on 01/27/20
16.50 -77.64%
on 06/19/20
-3.71 (-50.13%)
since 10/25/19

Most Recent Stories

More News
Nemaura Medical to Present at Virtual Diabetes Technology Meeting 2020

Nemaura Medical, Inc. (NASDAQ: NMRD)("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized...

NMRD : 3.69 (-3.15%)
New Stocks to watch in Biotech (NASDAQ: $SLRX), Cleantech (NASDAQ: $SPI), Tech (NYSE: $ASAN), Cannabis (CSE: $MSVN.C), Psychedelics (CSE: $FTRP.C), Vegan (NYSE: $LSF)

(MENAFN - Investor Ideas) Point Roberts, WA and Delta, BC - October 9, 2020 (Investorideas.com Newswire) Investorideas.com , a global news source and leading retail investor and trader resource, announces...

ALXN : 120.76 (-0.70%)
CMPS : 35.70 (-7.01%)
FBIO : 2.52 (-4.91%)
HSDT : 0.4238 (-5.30%)
KIN : 4.02 (-0.99%)
MBOT : 7.40 (-5.13%)
MCUR.CN : 0.670 (-9.46%)
MINE : 0.0001 (unch)
NMRD : 3.69 (-3.15%)
NWAV : 0.0088 (+7.32%)
NTN-H.VN : 0.175 (-7.89%)
LITT.VN : 0.020 (unch)
SPI : 7.94 (-4.34%)
SMS.VN : 0.285 (-5.00%)
TITXF : 0.1930 (-1.03%)
TOMDF : 0.0521 (-10.17%)
AMBS : 0.0055 (-8.33%)
Improving Diagnostic Devices Expand Patient Monitoring Capabilities

, /PRNewswire/ -- The medical device market is seeing steady growth thanks to new technologies and an emerging medical infrastructure around the world. Developing economies, which are investing more...

GRMN : 99.42 (-1.41%)
PFE : 37.92 (-0.68%)
LVGO : 136.67 (-1.61%)
NMRD : 3.69 (-3.15%)
MDT : 107.93 (-3.13%)
NVCR : 121.50 (-1.83%)
Exciting Innovations Push the Boundaries of Healthcare's Diagnostic Abilities

, /PRNewswire/ -- The wearable technology market is quickly evolving into a major tech segment, in large part thanks to consumer market growth which is driven by sales of smartwatches. Major companies...

ABT : 109.00 (+1.12%)
BAX : 80.01 (-1.33%)
GRMN : 99.42 (-1.41%)
INOTF : 0.1800 (-0.39%)
IRTC : 218.44 (-0.78%)
NMRD : 3.69 (-3.15%)
Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products

Clinically proven app from Healthimation, LLC, to be paired with Company's proBEAT(TM) non-invasive CGM system solution to offer convenient and effective management of pre-diabetes and Type 2 diabetes

NMRD : 3.69 (-3.15%)
Nemaura Medical Appoints Justin Mclarney as Chief Finance Officer

Nemaura Medical, Inc. (NASDAQ: NMRD)("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized...

NMRD : 3.69 (-3.15%)
Diagnostic Devices Give the Healthcare System New Avenues for Innovation

, /PRNewswire/ -- The recent pandemic, which has put a heavy toll on our economy and pushed the healthcare system into a severe scarcity problem, further illustrates the importance of medical devices...

OPK : 4.31 (+0.23%)
NMRD : 3.69 (-3.15%)
IBIO : 1.8500 (-4.15%)
CODX : 14.04 (+12.68%)
NVAX : 87.38 (-6.17%)
Medical Device Innovation Helps Propel Healthcare Systems to New Standards

, /PRNewswire/ -- In response to the outbreak, governments around the world have focused their resources on curing the viral infection. Beyond the longer-term promise of vaccines, a growing range of actions...

NMRD : 3.69 (-3.15%)
BNTX : 82.93 (-6.49%)
AMGN : 224.89 (-1.00%)
AZN : 53.07 (+2.06%)
GILD : 59.96 (-1.37%)
Nemaura Medical to Provide US proBEAT(TM) Launch Update at The LD 500 Virtual Conference

Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT(R),...

NMRD : 3.69 (-3.15%)
Medical Devices Become Widely Used as Healthcare Systems Look to Ease Burden

, /PRNewswire/ -- The pandemic has caused an exponential growth in demand for healthcare products such as ventilators, medical clothing, face masks, testing kits, monitoring and diagnostic devises. As...

NVAX : 87.38 (-6.17%)
NMRD : 3.69 (-3.15%)
ABT : 109.00 (+1.12%)
JNJ : 143.97 (-0.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar